Below you will find pages that utilize the taxonomy term “healthcare”
Posts
September 11 Wire Digest: Antares Lands $161M Space Reactor Award, Tempus Goes After Whole-Genome Scale
Friday’s wire leaned hard toward capital going into physical things. Reactors, cathode plants, industrial printers. The AI announcements were there too, but they had a different shape than they did a year ago, and that shift is the more interesting story.
Hardware got the big cheques Antares picked up a $161 million Strategic Breakthrough Award to demonstrate a space reactor. That is a demonstration contract, not a production one, and the gap between those two things has swallowed plenty of nuclear programs before.
Posts
Tempus AI (TEM) Q2 2026: The First Profitable Quarter Was a $97 Million Mark-to-Market Gain
Tempus AI reported GAAP net income of $5.6 million for the quarter ended June 30, the first positive bottom line in its public history, and the number is almost entirely an accounting event. Loss from operations widened to $75.9 million from $61.8 million a year earlier. The line that closed the gap was $97.4 million of fair value changes on marketable equity securities, non-cash and non-recurring by construction. Strip it out and Q2 was a larger operating loss on slower growth.
Posts
Integral Privacy Technologies Raises $25M to Build the Privacy Layer for AI's Real-World Data Push
Integral Privacy Technologies has raised $25 million in total funding, with backing from Venrex, The General Partnership, Array Ventures, GreatPoint Ventures, LiveRamp Ventures, Haystack, Virtue Ventures, Also Capital, Caffeinated Capital, LifeX Ventures, Circle & Co, and WS Investments. The round is aimed at scaling what the company calls its Forward Deployed Privacy Services — a service layer meant to make sensitive real-world data usable for AI training without triggering the regulatory and re-identification risks that normally keep that data locked away.
Posts
From Therapy to Augmentation: The Neural Implant Transition Nobody Has Regulated
The boundary between therapy and enhancement has always been unstable in medicine. A drug that treats depression in a diagnosed patient is a performance enhancer in a healthy one. The same logic will apply — is already beginning to apply — to neural implants. And unlike pharmaceuticals, the regulatory scaffolding for the augmentation case barely exists.
The GAO’s 2026 horizon report lists the capabilities that researchers are now actively working toward: hands-free drone control for military operators, real-time language translation, accelerated skill acquisition, and direct brain-to-brain communication.
Posts
Teamsters President to Join Henry Ford Genesys Nurses on Picket Line
Teamsters General President Sean M. O’Brien will join striking nurses and case workers at Henry Ford Genesys Hospital in Grand Blanc, Michigan on Tuesday, March 31 — a visible escalation of pressure on a hospital management that has refused to settle a strike now entering its seventh month.
The over 750 nurses and case workers, represented by Teamsters Local 332, have been on an unfair labor practice strike since September 1.
Posts
Hidden Belly Fat in Midlife Linked to Alzheimer's Disease
CHICAGO, Nov. 20, 2023 - Higher amounts of visceral abdominal fat in midlife are linked to the development of Alzheimer’s disease, according to research being presented next week at the annual meeting of the Radiological Society of North America (RSNA). Visceral fat is fat surrounding the internal organs deep in the belly. Researchers found that this hidden abdominal fat is related to changes in the brain up to 15 years before the earliest memory loss symptoms of Alzheimer’s disease occur.